Skip to main content
placeholder image

A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model

Journal Article


Abstract


  • © 2020 Australian and New Zealand Society for Immunology Inc. Regulatory T cells (Tregs) protect against graft-versus-host disease (GVHD), a life-threatening complication of allogeneic hematopoietic stem cell transplantation. The ectoenzyme CD39 is important for increasing the immunosuppressive function of Tregs. The rs10748643 (A → G) single-nucleotide polymorphism (SNP) in intron 1 of the human ENTPD1 gene is associated with increased proportions of CD39+ Tregs. This study aimed to determine whether the rs10748643 SNP corresponded to increased proportions of CD39+ Tregs in an Australian donor population, and whether this SNP influences clinical GVHD in a humanized mouse model. Donors were genotyped for the rs10748643 SNP by Sanger sequencing, and the proportion of CD39+ T cells in donor peripheral blood was determined by flow cytometry. Donors encoding the G allele (donorsAG/GG) demonstrated higher proportions of CD39+CD3+CD4+CD25+CD127lo Tregs, but not CD39+CD3+CD8+ T cells or CD39+CD3+CD4+ conventional T cells, compared with donors homozygous for the A allele (donorsAA). NOD-SCID-IL2Rγnull mice were injected with human peripheral blood mononuclear cells from either donorsAA (hCD39AA mice) or donorsAG/GG (hCD39AG/GG mice). hCD39AG/GG mice demonstrated significantly greater weight loss and GVHD clinical scores, and significantly reduced survival, compared with hCD39AA mice. hCD39AG/GG mice showed significantly higher hCD4+:hCD8+ T-cell ratios than hCD39AA mice, but displayed similar proportions of CD3+hCD4+hCD25+hCD127lo Tregs and hCD39+ Tregs. However, the proportion of human Tregs corresponded to survival in hCD39AA mice, but not in hCD39AG/GG mice. This study demonstrates that donors encoding the G allele show higher percentages of CD39+ Tregs, but cause worsened GVHD in humanized mice compared with donors homozygous for the A allele.

UOW Authors


  •   Adhikary, Sam (external author)
  •   Cuthbertson, Peter (external author)
  •   Turner, Ross J. (external author)
  •   Sluyter, Ronald
  •   Watson, Debbie

Publication Date


  • 2020

Citation


  • Adhikary, S., Cuthbertson, P., Turner, R., Sluyter, R. & Watson, D. (2020). A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model. Immunology and Cell Biology,

Scopus Eid


  • 2-s2.0-85083455817

Ro Metadata Url


  • http://ro.uow.edu.au/smhpapers1/1294

Has Global Citation Frequency


Place Of Publication


  • United Kingdom

Abstract


  • © 2020 Australian and New Zealand Society for Immunology Inc. Regulatory T cells (Tregs) protect against graft-versus-host disease (GVHD), a life-threatening complication of allogeneic hematopoietic stem cell transplantation. The ectoenzyme CD39 is important for increasing the immunosuppressive function of Tregs. The rs10748643 (A → G) single-nucleotide polymorphism (SNP) in intron 1 of the human ENTPD1 gene is associated with increased proportions of CD39+ Tregs. This study aimed to determine whether the rs10748643 SNP corresponded to increased proportions of CD39+ Tregs in an Australian donor population, and whether this SNP influences clinical GVHD in a humanized mouse model. Donors were genotyped for the rs10748643 SNP by Sanger sequencing, and the proportion of CD39+ T cells in donor peripheral blood was determined by flow cytometry. Donors encoding the G allele (donorsAG/GG) demonstrated higher proportions of CD39+CD3+CD4+CD25+CD127lo Tregs, but not CD39+CD3+CD8+ T cells or CD39+CD3+CD4+ conventional T cells, compared with donors homozygous for the A allele (donorsAA). NOD-SCID-IL2Rγnull mice were injected with human peripheral blood mononuclear cells from either donorsAA (hCD39AA mice) or donorsAG/GG (hCD39AG/GG mice). hCD39AG/GG mice demonstrated significantly greater weight loss and GVHD clinical scores, and significantly reduced survival, compared with hCD39AA mice. hCD39AG/GG mice showed significantly higher hCD4+:hCD8+ T-cell ratios than hCD39AA mice, but displayed similar proportions of CD3+hCD4+hCD25+hCD127lo Tregs and hCD39+ Tregs. However, the proportion of human Tregs corresponded to survival in hCD39AA mice, but not in hCD39AG/GG mice. This study demonstrates that donors encoding the G allele show higher percentages of CD39+ Tregs, but cause worsened GVHD in humanized mice compared with donors homozygous for the A allele.

UOW Authors


  •   Adhikary, Sam (external author)
  •   Cuthbertson, Peter (external author)
  •   Turner, Ross J. (external author)
  •   Sluyter, Ronald
  •   Watson, Debbie

Publication Date


  • 2020

Citation


  • Adhikary, S., Cuthbertson, P., Turner, R., Sluyter, R. & Watson, D. (2020). A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model. Immunology and Cell Biology,

Scopus Eid


  • 2-s2.0-85083455817

Ro Metadata Url


  • http://ro.uow.edu.au/smhpapers1/1294

Has Global Citation Frequency


Place Of Publication


  • United Kingdom